Fielmann Aktiengesellschaft (FLMNF)
USD 46.75
(0.0%)
USD 46.75
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 421.1 Million EUR | 544.89% |
| 2022 | 65.29 Million USD | -8.44% |
| 2021 | 71.31 Million USD | -0.8% |
| 2020 | 71.88 Million USD | 5188.55% |
| 2019 | 1.35 Million USD | 92.27% |
| 2018 | 707 Thousand EUR | -54.53% |
| 2017 | 1.55 Million EUR | 18.7% |
| 2016 | 1.31 Million EUR | 37.89% |
| 2015 | 950 Thousand EUR | -19.22% |
| 2014 | 1.17 Million EUR | 19.76% |
| 2013 | 982 Thousand EUR | -20.1% |
| 2012 | 1.22 Million EUR | -57.74% |
| 2011 | 2.9 Million EUR | -41.65% |
| 2010 | 4.98 Million EUR | -39.29% |
| 2009 | 8.21 Million EUR | 12.31% |
| 2008 | 7.31 Million EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - EUR | -100.0% |
| 2024 Q2 | 413.06 Million EUR | 0.0% |
| 2023 Q4 | 421.1 Million EUR | 0.0% |
| 2023 FY | 421.1 Million EUR | 544.89% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | 66.36 Million USD | 1.64% |
| 2023 Q2 | 70.04 Million USD | 5.54% |
| 2022 Q3 | 57.82 Million USD | -84.3% |
| 2022 Q1 | 366.04 Million EUR | -0.6% |
| 2022 Q2 | 368.27 Million EUR | 0.61% |
| 2022 Q4 | 65.29 Million USD | 12.93% |
| 2022 FY | 65.29 Million USD | -8.44% |
| 2021 Q1 | 339.78 Million EUR | -0.86% |
| 2021 FY | 71.31 Million USD | -0.8% |
| 2021 Q4 | 368.25 Million EUR | 1.71% |
| 2021 Q2 | 343.21 Million EUR | 1.01% |
| 2021 Q3 | 362.05 Million EUR | 5.49% |
| 2020 Q1 | 288.52 Million EUR | -2.73% |
| 2020 Q2 | 275.51 Million EUR | -4.51% |
| 2020 Q3 | 269.67 Million EUR | -2.12% |
| 2020 Q4 | 342.74 Million EUR | 27.1% |
| 2020 FY | 71.88 Million USD | 5188.55% |
| 2019 FY | 1.35 Million USD | 92.27% |
| 2019 Q2 | 302.57 Million EUR | -0.58% |
| 2019 Q3 | 303.91 Million EUR | 0.44% |
| 2019 Q1 | 304.34 Million EUR | 42947.38% |
| 2019 Q4 | 296.63 Million EUR | -2.39% |
| 2018 Q3 | 594 Thousand EUR | -53.56% |
| 2018 Q4 | 707 Thousand EUR | 19.02% |
| 2018 FY | 707 Thousand EUR | -54.53% |
| 2018 Q1 | 1.5 Million EUR | -2.96% |
| 2018 Q2 | 1.27 Million EUR | -15.24% |
| 2017 Q1 | 1.82 Million EUR | 39.59% |
| 2017 Q4 | 1.55 Million EUR | -29.48% |
| 2017 Q3 | 2.2 Million EUR | 12.44% |
| 2017 FY | 1.55 Million EUR | 18.7% |
| 2017 Q2 | 1.96 Million EUR | 7.24% |
| 2016 Q2 | 1.34 Million EUR | -4.26% |
| 2016 FY | 1.31 Million EUR | 37.89% |
| 2016 Q3 | 1.29 Million EUR | -4.23% |
| 2016 Q4 | 1.31 Million EUR | 1.55% |
| 2016 Q1 | 1.4 Million EUR | 48.11% |
| 2015 FY | 950 Thousand EUR | -19.22% |
| 2015 Q2 | 1.9 Million EUR | -3.21% |
| 2015 Q3 | 1.83 Million EUR | -3.31% |
| 2015 Q4 | 950 Thousand EUR | -48.31% |
| 2015 Q1 | 1.96 Million EUR | 67.01% |
| 2014 Q1 | 2.02 Million EUR | 106.31% |
| 2014 FY | 1.17 Million EUR | 19.76% |
| 2014 Q3 | 1.96 Million EUR | -2.0% |
| 2014 Q2 | 2 Million EUR | -1.18% |
| 2014 Q4 | 1.17 Million EUR | -40.06% |
| 2013 Q1 | 2.39 Million EUR | 94.96% |
| 2013 FY | 982 Thousand EUR | -20.1% |
| 2013 Q3 | 2.27 Million EUR | -2.78% |
| 2013 Q2 | 2.33 Million EUR | -2.46% |
| 2013 Q4 | 982 Thousand EUR | -56.78% |
| 2012 FY | 1.22 Million EUR | -57.74% |
| 2012 Q3 | - EUR | 0.0% |
| 2012 Q4 | 1.22 Million EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 Q4 | 2.9 Million EUR | 0.0% |
| 2011 FY | 2.9 Million EUR | -41.65% |
| 2011 Q1 | - EUR | -100.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 Q4 | 4.98 Million EUR | 0.0% |
| 2010 Q1 | - EUR | -100.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2010 FY | 4.98 Million EUR | -39.29% |
| 2009 FY | 8.21 Million EUR | 12.31% |
| 2009 Q4 | 8.21 Million EUR | 0.0% |
| 2008 FY | 7.31 Million EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | 40.293% |
| Ansell Limited | 706.6 Million USD | 40.405% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -1778.945% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -67276.16% |
| ConvaTec Group Plc | 1.22 Billion USD | 65.629% |
| ConvaTec Group Plc | 1.22 Billion USD | 65.678% |
| Encision Inc. | 67.33 Thousand USD | -625272.758% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -109894.854% |
| LifePoint, Inc. | 151.73 Thousand USD | -277425.802% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -8469.414% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -68371.707% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -233893.099% |
| SmileDirectClub, Inc. | 849.37 Million USD | 50.422% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -99.782% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -868346.452% |
| Vasamed, Inc. | 18.95 Thousand USD | -2222068.865% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -2280065.692% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -107751.554% |